本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

AN2 Therapeutics, Inc.

1.15
-0.0500-4.17%
盤後1.170.0200+1.74%19:01 EDT
成交量:141.99萬
成交額:161.10萬
市值:3,461.35萬
市盈率:-0.67
高:1.18
開:1.17
低:1.05
收:1.20
資料載入中...
2025/05/01

重要事件披露

Form 8-K - Current report
2025/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/25

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/05

重要事件披露

Form 8-K - Current report
2024/08/28

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/19

重要事件披露

Form 8-K - Current report
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

重要事件披露

Form 8-K - Current report